These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 16792602

  • 21. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
    Berto P, Bassi M, Incorvaia C, Frati F, Puccinelli P, Giaquinto C, Cantarutti L, Ortolani C.
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of sublingual immunotherapy.
    Passalacqua G, Guerra L, Pasquali M, Lombardi C, Canonica GW.
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):3-12; quiz 12-3, 103. PubMed ID: 15281466
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. New visions in specific immunotherapy in children: an iPAC summary and future trends.
    Halken S, Lau S, Valovirta E.
    Pediatr Allergy Immunol; 2008 Aug; 19 Suppl 19():60-70. PubMed ID: 18665964
    [Abstract] [Full Text] [Related]

  • 25. Practice parameters for sublingual immunotherapy.
    Ortolani C, Agostinis F, Amoroso S, Ariano R, Barbato A, Bassi M, Cadario G, Campi P, Cardinale F, Ciprandi G, D'Anneo R, Di Gioacchino M, Di Rienzo V, Fiocchi A, Galimberti M, Galli E, Giovannini M, Incorvaia C, La Grutta S, Lombardi C, Marcucci F, Marseglia G, Minelli M, Musarra A, Nettis E, Novembre E, Pajno G, Patriarca G, Pezzuto F, Piras P, Pucci S, Romano A, Romano C, Quercia O, Scala G, Schiavino D, Senna G, Sforza G, Tosca M, Tripodi S, Frati F.
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):44-6. PubMed ID: 16700194
    [Abstract] [Full Text] [Related]

  • 26. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year).
    Passalacqua G, Musarra A, Pecora S, Amoroso S, Antonicelli L, Cadario G, Di Gioacchino M, Lombardi C, Ridolo E, Sacerdoti G, Schiavino D, Senna G.
    Pediatr Allergy Immunol; 2007 Feb; 18(1):58-62. PubMed ID: 17295800
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites.
    Passalacqua G, Pasquali M, Ariano R, Lombardi C, Giardini A, Baiardini I, Majani G, Falagiani P, Bruno M, Canonica GW.
    Allergy; 2006 Jul; 61(7):849-54. PubMed ID: 16792583
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Multiallergen-specific immunotherapy in polysensitized patients: where are we?
    Bahceciler NN, Galip N, Cobanoglu N.
    Immunotherapy; 2013 Feb; 5(2):183-90. PubMed ID: 23413909
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Sublingual immunotherapy for treating respiratory allergy: a review on its effectiveness and suitability.
    Incorvaia C, Fuiano N, Leo G.
    Clin Ter; 2010 Feb; 161(6):543-7. PubMed ID: 21181085
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. An evidence based overview of sublingual immunotherapy in children.
    Scala G, Di Rienzo Businco A, Ciccarelli A, Tripodi S.
    Int J Immunopathol Pharmacol; 2009 Feb; 22(4 Suppl):23-6. PubMed ID: 19944006
    [Abstract] [Full Text] [Related]

  • 35. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM, Eigenmann PA.
    J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
    [No Abstract] [Full Text] [Related]

  • 36. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA, Röder E, Gerth van Wijk R, Al MJ, Hop WC, Rutten-van Mölken MP.
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [Abstract] [Full Text] [Related]

  • 37. Sublingual immunotherapy in children with allergic polysensitization.
    Ciprandi G, Cadario G, Di Gioacchino GM, Gangemi S, Gasparini A, Isola S, Marengo F, Minelli S, Ricciardi L, Ridolo E, Pravettoni V, Valle C, Verini M, Zambito M, Incorvaia C, Puccinelli P, Scurati S, Frati F, Simonetta M.
    Allergy Asthma Proc; 2010 Aug; 31(3):227-31. PubMed ID: 20615323
    [Abstract] [Full Text] [Related]

  • 38. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma.
    Rossi RE, Monasterolo G.
    Int J Immunopathol Pharmacol; 2005 Aug; 18(2):277-85. PubMed ID: 15888250
    [Abstract] [Full Text] [Related]

  • 39. Sublingual immunotherapy for allergic rhinitis: an update.
    Passalacqua G, Compalati E, Canonica GW.
    Curr Opin Otolaryngol Head Neck Surg; 2011 Feb; 19(1):43-7. PubMed ID: 21102336
    [Abstract] [Full Text] [Related]

  • 40. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
    Ciprandi G, Contini P, Pistorio A, Murdaca G, Puppo F.
    Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.